Use of the ASI titanium stent in the management of bladder outflow obstruction due to benign prostatic hyperplasia.
An expandable titanium intraprostatic stent was inserted into 30 patients with infravesical obstruction due to benign prostatic hyperplasia (BPH). All of the men were considered unsuitable for transurethral resection of the prostate as a result of comorbid conditions. In 25 patients effective micturition was reestablished with this technique. In 21 of these men, who have been followed for longer than 1 year, the mean maximum flow rate at 1 year was 10.8 ml. per second and the mean residual urine was 56 ml. Although urinary tract infections occurred subsequent to stent insertion in 10 individuals, these resolved after appropriate antibiotic treatment and no stents have had to be removed for this reason. Followup cystoscopy or examination by electron microscopy of those stents that have been removed has shown partial epithelialization of the stent surface in a proportion of patients, and a minor degree of incrustation occurred in 1 case. We conclude that an expandable intraprostatic titanium stent is an acceptable alternative to transurethral resection of the prostate or long-term catheterization in this particular group of high risk patients.
Kirby
R S
RS
Department of Urology, St. Bartholomew's Hospital, London, England.
Heard
S R
SR
Miller
P
P
Eardley
I
I
Holmes
S
S
Vale
J
J
Bryan
J
J
Liu
S
S
D000368:Aged; D001424:Bacterial Infections / Q000209:etiology; D004848:Epithelium / Q000648:ultrastructure; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D011470:Prostatic Hyperplasia / Q000150:complications*; D015607:Stents / Q000009:adverse effects; D014025:Titanium; D001748:Urinary Bladder Neck Obstruction / Q000209:etiology / Q000382:microbiology / Q000473:pathology / Q000628:therapy*
D014025:Titanium